A group of heavyweight biotech industry executives, including the former CEO of pharmaceutical giant Pfizer Inc., have formed a new Baltimore biotech company.
Centrexion Corp. has raised a total of $23.4 million since its incorporation in February, according to recent Form D filings with the Securities and Exchange Commission.
{iframe}http://www.bizjournals.com/baltimore/news/2013/12/27/former-pfizer-chief-joins-team-to.html{/iframe}